Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus in Active Systemic Lupus Erythematosus (SIRIUS)
NCT04582136Phase 3Active, not recruiting
- Sponsor
- Chinese SLE Treatment And Research Group
- Start
- Mar 2021
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sirolimus in systemic lupus erythematosus (SLE), sponsored by Chinese SLE Treatment And Research Group. Started Mar 2021; status: active, not recruiting.
02
Drugs
sirolimus
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT04582136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04582136.